Insider Trading: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

9.23USD
22 May 2015
Change (% chg)

-- (--)
Prev Close
$9.23
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,622,269
52-wk High
$16.87
52-wk Low
$2.65

Search Stocks
Qvt Associates Gp L L C Options Exercised: 0
Trade Date: Monday, 1 Jul 2013 Price: 6.30
Title: Beneficial Owner of More than 10% Class Shares Held: 12,931,101
Type Traded: Indirect Net Change in Shares This Filing: 1,963,248

Institutional Holders

% Shares Owned: 93.85%
# of Holders: 225
Total Shares Held: 110,323,994
3 Mo. Net Change: 15,758,484
# New Positions: 32
# Closed Positions: 43
# Increased Positions: 124
# Reduced Positions: 88
# Net Buyers: 36

Officers & Directors

Name Age Since Current Position

David Scheer

62 2010 Chairman of the Board

Milind Deshpande

58 2013 President, Chief Executive Officer, Director

Mary Fenton

51 2010 Chief Financial Officer, Senior Vice President

David Apelian

49 2013 Executive Vice President, Chief Medical Officer

Joseph Truitt

50 2014 Executive Vice President, Chief Commercial Officer

Michael Kishbauch

65 2013 Director

Jason Fisherman

58 2000 Independent Director

Gary Frashier

78 2008 Independent Director

Kurt Graves

47 2012 Independent Director

Dennis Liotta

66 2008 Independent Director

Robert Van Nostrand

58 2007 Independent Director

Nicole Vitullo

58 2010 Independent Director
Search Stocks